UK markets close in 4 hours 21 minutes

Tekla Life Sciences Investors (HQL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
13.28+0.20 (+1.53%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
23,524
23,524
-103,250
65,688
124,083
Operating expenses
Selling general and administrative
903.138
903.138
1,077
844.018
751.317
Total operating expenses
1,171
1,171
1,353
1,158
1,030
Income before tax
22,352
22,352
-104,603
64,531
123,053
Income from continuing operations
22,352
22,352
-104,603
64,531
123,053
Net income
22,352
22,352
-104,603
64,531
123,053
Net income available to common shareholders
22,352
22,352
-104,603
64,531
123,053
Basic EPS
0.79
-
-4.26
2.66
5.16
Diluted EPS
0.79
-
-4.26
2.66
5.16
Basic average shares
28,294
-
24,555
24,260
23,847
Diluted average shares
28,294
-
24,555
24,260
23,847